Acute asthma exacerbations: an overview

Domenico Lorenzo Urso

DOI: https://doi.org/10.7175/rhc.v5i3.932

Abstract

Asthma is a chronic inflammatory disease of the airways. All patient with asthma are at risk of having exacerbations characterized by worsening symptoms, airflow obstruction, and an increased requirement for rescue bronchodilators. Asthma exacerbations can be classified as mild, moderate, severe, or life threatening. The goals of treatment are correction of severe hypoxemia, rapid reversal of airflow obstruction, and reduction of the risk of relapse.

Keywords

Asthma; Exacerbations; Guidelines

Full Text

HTML PDF

References

  • Eder W, Ege MJ, von Mutius E. The asthma epidemic. N Engl J Med 2006; 355: 2226-35; http://dx.doi.org/10.1056/NEJMra054308
  • Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA), 2012. Available at: http://www.ginasthma.org
  • National Institutes of Health, National Heart, Lung and Blood Institute National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma, 2007. Available at http://www.nhlbi.nih.gov/guidelines/asthma/
  • BTS, British Thoracic Society Scottish Intercollegiate Guidelines Network. British Guideline on the Management of Asthma. Thorax 2008; 63(Suppl iv): 1-121; http://dx.doi.org/10.1136/thx.2008.097741
  • Reddel HK, Taylor DR, Bateman ED, et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 2009; 180: 59-99; http://dx.doi.org/10.1164/rccm.200801-060ST
  • Tattersfield AE, Postma DS, Barnes PJ, et al. Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group. Am J Respir Crit Care Med 1999; 160: 594–9; http://dx.doi.org/10.1164/ajrccm.160.2.9811100
  • Kolbe J, Fergusson W, Garret J. Rapid onset asthma: a severe but uncommon manifestation. Thorax 1998; 53: 241-7; http://dx.doi.org/10.1136/thx.53.4.241
  • Weiss KB, Sullivan SD, Lyttle CS. Trend in the cost illness for asthma in the United States 1985- 1994. J Allergy Clin Immunol 2000; 106: 493- 9; http://dx.doi.org/10.1067/mai.2000.109426
  • Bai TR, Von KJM, Postma DS, et al. Severe exacerbations predict excess lung function decline in asthma. Eur Resp J 2007; 30: 452-6; http://dx.doi.org/10.1183/09031936.00165106
  • Rodrigo GJ, Rodrigo C, Hall JB. Acute asthma in adults: a review. Chest 2004; 125: 1081-102; http://dx.doi.org/10.1378/chest.125.3.1081
  • Urso DL. Treatment for acute asthma in the Emergency Department: practical aspects. Eur Rev Med Pharmacol Sci 2010; 14: 209-14
  • Rowe BH, Voaklander DC, Wang D, et al. Asthma presentations by adults to emergency departments in Alberta, Canada: a large population-based study. Chest 2009; 135: 57-65; http://dx.doi.org/10.1378/chest.07-3041
  • Weber EJ, Silverman RA, Callaham ML, et al. A prospective multicenter study of factors associated with hospital admission among adults with acute asthma. Am J Med 2002; 113: 371-8; http://dx.doi.org/10.1016/S0002-9343(02)01242-1
  • Braman SS, Kaemmerlen JT. Intensive care of status asthmaticus: a 10-years experience. JAMA 1990; 264: 366-8; http://dx.doi.org/10.1001/jama.264.3.366
  • Moorman JE, Rudd RA, Johnson CA, et al; Centers for Disease Control and Prevention (CDC). National surveillance for asthma – United States, 1984-2004. MMWR Surveill Summ 2007; 56: 1-54
  • Göksel O, Celik GE, Erkekol FO, et al. Triggers in adult asthma: are patients aware of triggers and doing right? Allerg Immunopathol 2009; 37: 122-8; http://dx.doi.org/10.1016/S0301-0546(09)71723-9
  • Harrison BD. Difficult asthma in adult: recognition and approaches to management. Intern Med J 2005; 35: 543-7; http://dx.doi.org/10.1111/j.1445-5994.2005.00901.x
  • Hodder R, Lougheed MD, Rowe BH, et al. Management of acute asthma in adult in the emergency department: non ventilator management. CMAJ 2010; 182: 265-72; http://dx.doi.org/10.1503/cmaj.080072
  • Proceeding of the ATS Workshop on Refractory Asthma. Am J Respir Crit Care Med 2000; 162: 2341-51; http://dx.doi.org/10.1164/ajrccm.162.6.ats9-00
  • 20.Urso DL, Vincenzo D, Pignataro F, et al. Diagnosis and treatment of refractory asthma. Eur Rev Med Pharmacol Sci 2008; 12: 315-320
  • Bousquet J, Cabrera P, Berkman N, et al. The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma. Allergy 2005; 60: 302-8; http://dx.doi.org/10.1111/j.1398-9995.2004.00770.x
  • Haldar P, Pavord ID, Show DE, et al. Cluster analysis and clinical asthma phenotypes. Am J Resp Crit Car Med 2008; 178: 218-24; http://dx.doi.org/10.1164/rccm.200711-1754OC
  • Restrepo RD, Peters J. Near-fatal asthma: recognition and management. Curr Opin Pulm Med 2008; 14: 13-23; http://dx.doi.org/10.1097/MCP.0b013e3282f1982d
  • Roy SR, Milgron H. Management of the acute exacerbation of asthma. J Asthma 2003; 40: 593-604
  • Lazarus SC. Emergency treatment of asthma. N Engl Med J 2010; 363: 755-64; http://dx.doi.org/10.1056/NEJMcp1003469
  • Gervais P, Larouche I, Blais L, et al. Asthma management at discharge from the emergency department: a descriptive study. Can Respir J 2005; 12: 219-22
  • Silverman Ra, Flaster E, Enright PL, et al. FEV1 performance among patients with acute asthma. Chest 2007; 131: 164-71; http://dx.doi.org/10.1378/chest.06-0530
  • Rodrigo GJ, Rodriquez Verde M, Peregalli V, et al. Effects of short-term 28% and 100% oxygen on PaCO2 and peak expiratory flow rate in acute asthma: a randomized trial. Chest 2003; 124: 1312-7; http://dx.doi.org/10.1378/chest.124.4.1312
  • Cates CJ, Crilly JA, Rowe BH. Holding chambre (spacers) versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev 2006; 2: CD000052
  • Camargo CA Jr, Spooner CH, Rowe BH. Continous versus intermittent beta-agonists in the treatment of acute asthma. Cochrane Database Syst Rev 2003; 4: CD001115
  • Rodrigo GJ, Castro-Rodriguez JA. Anticholinergics in the treatment of children and adults with acute asthma: a systematic review with meta-analysis. Thorax 2005; 60: 740-6; http://dx.doi.org/10.1136/thx.2005.047803
  • 32.Gelb AF, Karpel J, Wise RA, et al. Bronchodilator efficacy of the fixed combination of ipratropium and albuterol compared to albuterol alone in moderate-to-severe persistent asthma. Pulm Pharmacol Ther 2008; 21: 630-6; http://dx.doi.org/10.1016/j.pupt.2008.02.005
  • Fiel SB, Vincken W. Systemic corticosteroid therapy for acute asthma exacerbations. J Asthma 2006; 43: 321-31; http://dx.doi.org/10.1080/02770900600567163
  • Rowe BH, Spooner C, Ducharme FM, et al. Early emergency department treatment of acute asthma with systemic corticosteroids. Cochrane Database Syst Rew 2001: CD002178
  • Rodrigo G, Rodrigo C. Corticosteroids in the emergency department therapy of acute adult asthma: an evidence-based evaluation. Chest 1999; 116: 285-95; http://dx.doi.org/10.1378/chest.116.2.285
  • Edmonds ML, Camargo CA, Pollack CV, et al. Early use of inhaled corticosteroids in the emergency department treatment of acute asthma. Cochrane Database Syst Rew 2003: CD002308
  • Parameswaran K, Belda J, Rowe BH. Addition of intravenous aminophylline to beta2-agonists in adults with acute asthma. Cochrane Database Syst Rev 2000; CD002742
  • Urso DL, Luchetti L. Efficacia e sicurezza dei farmaci broncodilatatori nel paziente anziano affetto da bronco pneumopatia cronica ostruttiva (BPCO). G Geront 2005; 53: 73-5
  • Dalhen SE. Treatment of asthma with antileukotrienes: first line or last resort therapy? Eur J Pharmacol 2006: 533: 40-56; http://dx.doi.org/10.1016/j.ejphar.2005.12.070
  • Montuschi P. Role of leukotrienes and leukotriene modifiers in asthma. Pharmaceutical 2010; 3: 1792-811
  • Kluitert LME, Watson D. Antileukotrienes as adjunctive therapy in acute asthma. Drug 2007; 67: 1665-70; http://dx.doi.org/10.2165/00003495-200767120-00002
  • Urso DL, Vincenzo D, Formaro F, et al. Role of antileukotrienesin acute asthma exacerbations. Review in Health Care 2012; 3: 75-81
  • Rowe BH, Spooner C, Ducharme FM, et al. Magnesium sulfate for treating exacerbations of acute asthma in the emergency department. Cochrane Database Syst Rev 2000; 4: CD001490
  • Rodrigo G, Pollack C, Rodrigo C, et al. Heliox for nonintubated acute asthma patients. Cochrane Database Syst Rev 2006; 4: CD002884
  • Ram FS, Wellington S, Rowe BH, et al. Non-invasive positive pressure ventilation for treatment of respiratory failure due to severe acute exacerbations of asthma. Cochrane Database Syst Rev 2005; CD004360
  • Soroksky A, Stav D, Shpirer I. A pilot prospective, randomized placebo-controlled trial of bilevel positive airway pressure in acute asthmatic attack. Chest 2003; 123: 1018-25; http://dx.doi.org/10.1378/chest.123.4.1018
  • FitzGerald JM. The management of acute life-threatening asthma. Eur Respir Monit 2003; 23: 396-408
  • Aldington S, Beasley R. Asthma exacerbations: Assessment and management of severe asthma in adults in hospital. Thorax 2007; 62: 447-58; http://dx.doi.org/10.1136/thx.2005.045203
  • 49.Rowe BH, Spooner CH, Ducharme FM, et al. Corticosteroids for preventing relapse following acute exacerbations of asthma. Cochrane Database Syst Rev 2007; CD000195

Statistics

Abstract: 1791 views
HTML: 1355 views
PDF: 2438 views

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.